Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,772 | -87,966 | -29,582 | -19,111 | -9,864 |
| Depreciation Amortization | 92 | 49,021 | 280 | 187 | 93 |
| Other Working Capital | -625 | 2,368 | 3,679 | 57 | -571 |
| Other Operating Activity | 1,381 | 8,153 | 6,679 | 4,494 | 2,186 |
| Operating Cash Flow | $-9,924 | $-28,424 | $-18,944 | $-14,373 | $-8,156 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 56,409 | 84,833 | 84,833 | 84,833 | 84,833 |
| End Cash Position | 46,485 | 56,409 | 65,889 | 70,460 | 76,677 |
| Net Cash Flow | $-9,924 | $-28,424 | $-18,944 | $-14,373 | $-8,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,924 | -28,424 | -18,944 | -14,373 | -8,156 |
| Free Cash Flow | -9,924 | -28,424 | -18,944 | -14,373 | -8,156 |